Skip to main content
Kolinpharma logo

Kolinpharma — Investor Relations & Filings

Ticker · KIP ISIN · IT0005322950 LEI · 815600FC8F1A3BED2743 XMIL Manufacturing
Open in API
Filings indexed 222 across all filing types
Latest filing 2023-08-11 M&A Activity
Country IT Italy
Listing XMIL KIP

About Kolinpharma

https://www.kolinpharma.com/index-en

Kolinpharma is a nutraceutical company established in 2013, specializing in the research and development of innovative products designed to improve well-being and quality of life. The company's core activities are centered on scientific research and product innovation, creating high-quality nutraceuticals. It operates an in-house R&D department and collaborates with leading universities for in-vitro and clinical studies. As a certified B Corporation, Kolinpharma adheres to high standards of social and environmental performance. The company distributes its proprietary branded products through a qualified network of medical-scientific representatives.

Recent filings

Filing Released Lang Actions
Offerta pubblica d'acquisto volontaria promossa da Igea Holding sulle az.di Kolinpharma-conferimento nell'offerente della partecipazione di PRP Srl
M&A Activity Classification · 1% confidence The document is an official communication from Kolinpharma S.p.A. regarding a 'Voluntary Total Takeover Bid' (Offerta pubblica d'acquisto volontaria totalitaria) promoted by Igea Holding S.p.A. The subject explicitly details a takeover/merger activity involving the acquisition of shares. This directly corresponds to the definition of M&A Activity (TAR). The document discusses the settlement of the offer, the resulting shareholdings, and the upcoming 'Sell-Out Period' (Obbligo di Acquisto), confirming it is a core document related to a takeover proposal.
2023-08-11 Italian
Offerta pubblica d'acquisto promossa da Igea Holding sulle azioni di Kolinpharma- Acquisti fuori Opa
M&A Activity Classification · 1% confidence The document is an official communication from Kolinpharma S.p.A. regarding a voluntary takeover bid (Offerta Pubblica di Acquisto Volontaria Totalitaria) promoted by Igea Holding S.p.A. Specifically, the subject is 'Acquisti fuori Opa' (Purchases outside the tender offer) and it details the results of the offer period, the resulting shareholding percentage (91.894%), and the mandatory 'Sell-Out' period (Obbligo di Acquisto ex articolo 108, comma 2, del TUF) that must follow when the acquirer crosses the 90% threshold. This type of announcement, detailing the outcome of a tender offer and subsequent mandatory actions, falls under the category of Merger & Acquisition (M&A) activity or takeover bids. The most appropriate code among the provided definitions is 'TAR' (M&A Activity), as it directly relates to the takeover process described.
2023-08-08 Italian
Offerta pubblica d'acquisto volont.promossa da IGEA Holding S.p.A.sulle azioni di Kolinpharma S.p.A.- RIsultati definitivi dell'offerta ex art.108 TUF
M&A Activity Classification · 1% confidence The document is an official communication from Kolinpharma S.p.A. regarding a voluntary takeover bid ('Offerta pubblica d'acquisto volontaria totalitaria') promoted by Igea Holding S.p.A. Specifically, the subject line and main headings clearly state 'RISULTATI DEFINITIVI DELL'OFFERTA' (Final Results of the Offer) and detail the subsequent mandatory purchase obligation ('Obbligo di Acquisto ex articolo 108, comma 2, del TUF'). This document announces the final outcome of a tender offer and the subsequent steps for remaining shareholders, which falls under corporate actions related to takeovers or mergers. The closest matching category is 'M&A Activity' (TAR), as it directly concerns the finalization of a takeover bid.
2023-08-07 Italian
Opa volontaria totalitaria promossa da Igea Holding sulle azioni Kolinpharma- Conclusione periodo d'adesione-Risultati provvisori dell'offerta
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official communication regarding an 'OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA' (Voluntary Total Tender Offer) for the shares of Kolinpharma S.p.A. Specifically, it announces the 'CONCLUSIONE DEL PERIODO DI ADESIONE ALL'OFFERTA' (Conclusion of the Offer Acceptance Period) and reports the 'RISULTATI PROVVISORI DELL'OFFERTA' (Provisional Offer Results). This type of announcement, detailing the outcome of a tender offer (merger/takeover activity), falls under the category of M&A Activity (TAR). Although it is a formal regulatory communication, the specific subject matter (Tender Offer Results) is more precise than the general 'RNS' fallback. It is not a general announcement of a report (RPA) because it contains substantive results and legal determinations (like waiving the threshold condition), rather than just stating a report is available.
2023-08-04 Italian
Adesioni offerta pubblica d'acquisto volontaria totalitaria promossa da Igea holding sulle azioni Kolinpharma, superamento della soglia del 90%
M&A Activity Classification · 1% confidence The document is an official communication ('Informazione Regolamentata') from Kolinpharma S.p.A. regarding a Tender Offer ('Offerta Pubblica di Acquisto Volontaria Totalitaria') promoted by Igea Holding S.p.A. The key subject is the successful acquisition of shares outside the tender offer, leading to the Offeror exceeding the 90% ownership threshold. This event triggers the automatic delisting of the shares from Euronext Growth Milan. This type of announcement, detailing the status and potential outcome (delisting) of a takeover bid, falls under Merger & Acquisition (M&A) activity. The code 'TAR' (M&A Activity) is the most appropriate classification, as it directly relates to takeover proposals and related corporate actions.
2023-08-03 Italian
KOLINPHARMA, CDA approva i KPI del secondo trimestre 2023 e prende atto del fatturato del primo semestre
Earnings Release Classification · 1% confidence The document is a formal announcement from KOLINPHARMA dated July 28, 2023, detailing preliminary financial results for the first half (1H) of 2023 and Key Performance Indicators (KPIs) for the second quarter (2Q) of 2023. The subject line explicitly mentions 'CDA approva i KPI del secondo trimestre 2023 e prende atto del fatturato del primo semestre' (Board approves Q2 2023 KPIs and takes note of H1 turnover). This content—a summary of key financial metrics for a specific period (half-year/quarter) released shortly after the period ends—is characteristic of an Earnings Release (ER). It provides key highlights (turnover figures, prescription growth) but is not the comprehensive annual report (10-K) or the detailed interim report (IR), as it explicitly states the turnover data is 'preliminary' and not yet audited. Since it is the initial announcement of period results, ER is the most appropriate classification. H1 2023
2023-07-28 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.